The Chilean market for Penicillins and Streptomycins in dosage forms has experienced fluctuating growth rates over the past decade. Between 2013 and 2023, the market size increased from approximately $61.6M to $69.0M, indicating variable growth patterns. The most significant annual decrease occurred in 2017 with a drop of 11.56%, followed by a recovery phase over subsequent years. With a slight increase in 2023 (0.58% from 2022), the five-year compound annual growth rate (CAGR) stands at 0.71%, suggesting moderate growth.
- Potential for innovation in antibiotic formulations.
- Market expansion driven by increased healthcare access.
- Regulatory influences affecting antibiotic usage.
How does Chile rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 14 | 14 Thailand | 89,928,000 | 2023 | +4.19% | +3.03% | View data |
| 15 | 15 Peru | 80,808,000 | 2023 | +1.93% | +2.15% | View data |
| 16 | 16 Chile | 68,962,000 | 2023 | +0.58% | +0.71% | |
| 17 | 17 Malaysia | 62,268,000 | 2023 | +7.35% | +7.89% | View data |
| 18 | 18 Czech Republic | 60,391,000 | 2023 | -3.18% | -4.46% | View data |
